NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
02/03/2026
Back to search
Official data from USPTO
SUTRO BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/04/2026
Classification
Registered
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
05/16/2018
Registration date
03/05/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2026
Last transaction
02/04/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/05/2017
First use in commerce
07/05/2017
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA
Examiner
MARTIN,CHRISTINE C
Current location
Historical data usage
Mark description
The mark consists of the word "SUTRO BIOPHARMA" in stylized font with the letter "O" in the word "SUTRO" having a dot on the left side of the fanciful "O" to the right of the letter "R" all centered above the word "BIOPHARMA".
Holders and representatives
Holders
Sutro Biopharma, Inc.
Representatives
Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsproteins and derivatives thereof for prophylacticdiagnostictherapeutic use in the nature of treating cancer * in humans *cardiovascularhematopoieticcentral nervous systemautoimmuneinfectiousskin and skin structurebonegeneticendocrine or metabolic type diseases and ailments in humans and animals
Class 40
Manufacture of pharmaceutical preparations for others
Class 42
Research and development of pharmaceutical preparations for others
Publications
History of USPTO decisions and trademark events.
42 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/09/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/09/2026
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
01/09/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/06/2026
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
01/06/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2025
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
06/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/17/2025
E815
TEAS SECTION 8 & 15 RECEIVED
02/25/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/25/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/25/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/18/2018
PUBO
PUBLISHED FOR OPPOSITION
12/18/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/28/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/15/2018
ALIE
ASSIGNED TO LIE
11/12/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/26/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2018
GNRT
NON-FINAL ACTION E-MAILED
09/05/2018
CNRT
NON-FINAL ACTION WRITTEN
09/05/2018
DOCK
ASSIGNED TO EXAMINER
08/30/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/24/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2018
NWAP
NEW APPLICATION ENTERED
05/19/2018
Continuous trademark protection
Get notified about every new filing that threatens SUTRO BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.